Web22 sep. 2024 · CKD, chronic kidney disease; EF, ejection fraction; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; HF, heart failure; MR, mitral regurgitation; NT-proBNP, N-terminal pro-B-type natriuretic peptide; NYHA, New York Heart Association; RCT, randomized controlled trial. Renal outcome WebChronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets. / van de Wouw, Jens; Broekhuizen, Michelle; Sorop, Oana et al. In: Frontiers in Physiology, Vol. 10, 1108, 2024. Research output: Contribution to journal › Article › Academic
SGLT2 Inhibitors in HFpEF CFR Journal
Web23 apr. 2024 · In the US, the annual direct cost of heart failure (HF) is estimated at over $30 billion, largely driven by the >1 million hospitalizations in which HF is the primary … Web9 aug. 2016 · Renal insufficiency perpetuates systemic inflammation and oxidative stress, well-known instigators in cardiovascular disease. Importantly, the systolic (and diastolic) … demand reasons
Echocardiographic parameters and renal outcomes in patients with ...
Web12 apr. 2024 · Heart failure (HF) with preserved ejection fraction (HFpEF) has a complex aetiology and has been increasing in multiple ethnicities with a variety of lifestyles and related phenotypes. 1 Most previous studies have failed to show effective treatment for HFpEF other than sodium–glucose cotransporter 2 (SGLT2) inhibitors; thus, a ‘one size … Web5 jan. 2024 · Instead, it’s an estimation. But certainly, when a doctor says your ejection fraction is under 20 percent or only five percent, there is no mistake that you have a … WebThis was an international, multicenter trial including patients with ejection fraction greater than 40% and estimated glomerular filtration rate (eGFR) of 25 mL/min/1.73 m2 or … demand reasons for international trade